Count | |
7 | |
14 | |
40 | |
20 | |
1 | |
1 | |
1 | |
1 | |
2 | |
6 | |
2 | |
2 | |
3 | |
1 | |
1 | |
1 | |
6 | |
1 | |
1 | |
1 | |
Interferon Alfa-2b/*adverse effects/pharmacology/therapeutic use | 1 |
2 | |
1 | |
1 | |
8 | |
9 | |
11 | |
1 | |
1 | |
1 | |
1 | |
22 | |
1 | |
1 | |
1 | |
7 | |
4 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
8 | |
3 | |
2 | |
1 | |
15 | |
7 | |
64 | |
6 | |
38 | |
11 | |
23 | |
13 | |
2 | |
2 | |
10 | |
1 | |
4 | |
12 | |
1 | |
6 | |
1 | |
4 | |
1 | |
12 | |
1 | |
4 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
3 | |
2 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
2 | |
1 | |
Interferon Type I, Recombinant/*pharmacology/therapeutic use | 2 |
2 | |
5 | |
9 | |
Interferon-alpha/metabolism/*pharmacokinetics/*therapeutic use | 5 |
3 | |
3 | |
1 | |
1 | |